Beam Therapeutics (BEAM) News Today → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free BEAM Stock Alerts $22.74 -0.73 (-3.11%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBeam Therapeutics (NASDAQ:BEAM) Receives Outperform Rating from Wedbushamericanbankingnews.com - April 24 at 4:42 AMBeam Therapeutics: A 'Hold' Amid High Valuation And Uncertain Revenue Prospectsseekingalpha.com - April 23 at 9:48 PMBeam Therapeutics (NASDAQ:BEAM) Stock Rating Reaffirmed by Wedbushmarketbeat.com - April 23 at 12:34 PMBeam Therapeutics Stock (NASDAQ:BEAM): Investing in Cutting-Edge Gene Editingmsn.com - April 22 at 8:50 PMInternational Assets Investment Management LLC Makes New $1.85 Million Investment in Beam Therapeutics Inc. (NASDAQ:BEAM)marketbeat.com - April 21 at 4:26 AMBeam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by Sumitomo Mitsui Trust Holdings Inc.marketbeat.com - April 19 at 5:29 AMBeam Therapeutics Inc. (NASDAQ:BEAM) Receives Consensus Recommendation of "Hold" from Brokeragesamericanbankingnews.com - April 19 at 4:46 AMBeam Therapeutics Inc. (BEAM)finance.yahoo.com - April 18 at 12:15 PMBeam Therapeutics Inc. (NASDAQ:BEAM) Short Interest Down 6.1% in Marchamericanbankingnews.com - April 17 at 5:12 AMMirae Asset Global Investments Co. Ltd. Reduces Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)marketbeat.com - April 16 at 5:04 AMTV sex coach who uses ‘touch’ in therapy sued for rape by clientyahoo.com - April 14 at 5:22 PMNASDAQ:BEAM (Beam Therapeutics)fool.ca - April 13 at 10:51 PMNew Delhi: Radiation therapy facility started in Lady Hardinge Hospitalmsn.com - April 13 at 5:50 PMBeam Therapeutics (NASDAQ:BEAM) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - April 11 at 7:55 AMBeam Therapeutics Inc. (NASDAQ:BEAM) Shares Sold by Baillie Gifford & Co.marketbeat.com - April 11 at 7:23 AMPoseida Therapeutics (PSTX) Gets a Buy from William Blairmarkets.businessinsider.com - April 9 at 12:08 AMQ1 2024 EPS Estimates for Beam Therapeutics Inc. Decreased by Analyst (NASDAQ:BEAM)marketbeat.com - April 5 at 8:21 AMGiuseppe Ciaramella Sells 4,534 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM) Stockinsidertrades.com - April 5 at 7:20 AMBeam Therapeutics president sells over $145k in company stockinvesting.com - April 5 at 1:26 AMBeam Therapeutics Inc. (NASDAQ:BEAM) CFO Sells $174,925.52 in Stockinsidertrades.com - April 4 at 6:38 AMTAE Life Sciences' Neutron Beam System Receives Acceptance, Allowing BNCT Clinical Trials to Begin in Chinafinance.yahoo.com - April 3 at 2:40 PMBeam Dynamics, Three Strands Recovery Wear take home top prizes at Winston Starts’ pitch competitionbizjournals.com - April 3 at 9:39 AMBeam Therapeutics: A Buy Rating Amidst Gene Editing Industry Developmentsmarkets.businessinsider.com - April 2 at 11:38 PMGene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterolmsn.com - April 2 at 3:57 PMBeam Therapeutics (NASDAQ:BEAM) Shares Gap Down on Insider Sellingmarketbeat.com - April 2 at 10:27 AMHelen Flanagan beams as she poses with her young son following psychosis diagnosismsn.com - April 2 at 8:19 AMBeam Therapeutics Inc. (NASDAQ:BEAM) CEO Sells $2,031,600.00 in Stockinsidertrades.com - April 2 at 4:10 AMVanguard Group Inc. Trims Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)marketbeat.com - April 2 at 4:09 AMJohn M. Evans Sells 60,000 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM) Stockmarketbeat.com - April 1 at 6:31 PMBeam Therapeutics Inc. (NASDAQ:BEAM) Sees Significant Increase in Short Interestmarketbeat.com - April 1 at 1:39 PMIs Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game?msn.com - March 30 at 7:20 PMLaw enforcement break windows, kick down doors as they search Beam Hall and the Student Unionyahoo.com - March 30 at 2:20 PMThe 6 Best Cold Laser Therapy Devices for At-Home Healingmsn.com - March 29 at 6:17 PMThese Cold Laser Therapy Devices Will Help Transform Your Skinyahoo.com - March 29 at 6:17 PMBlind Dog Recovers from Losing Eyes & Ear to Become Therapy Dogmsn.com - March 29 at 1:16 PMARK Investment Management LLC Acquires 609,998 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)marketbeat.com - March 28 at 6:39 AMExpert Outlook: Beam Therapeutics Through The Eyes Of 4 Analystsmarkets.businessinsider.com - March 27 at 1:38 PMBeam Therapeutics (NASDAQ:BEAM) Rating Reiterated by BMO Capital Marketsmarketbeat.com - March 27 at 11:01 AMBeam Therapeutics To Start Clinical Study Of BEAM-302 In Alpha-1 Antitrypsin Deficiency In UKmarkets.businessinsider.com - March 26 at 9:06 AMBeam Therapeutics Announces Clearance of Clinical Trial Authorisation Application for BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)globenewswire.com - March 26 at 6:30 AMBeam Therapeutics Inc. (BEAM) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - March 25 at 8:18 PMChennia Apollo cancer centre trains international docs in proton beam therapymsn.com - March 23 at 3:00 AMQ1 2024 Earnings Estimate for Beam Therapeutics Inc. (NASDAQ:BEAM) Issued By Leerink Partnrsmarketbeat.com - March 21 at 7:45 AMBeam Therapeutics Inc. Expected to Post FY2025 Earnings of ($5.38) Per Share (NASDAQ:BEAM)marketbeat.com - March 20 at 6:55 AMTennessee pitcher Drew Beam hit hard by Alabama baseball in 6-3 lossusatoday.com - March 17 at 9:41 AMBEAM Mar 2024 40.000 putfinance.yahoo.com - March 16 at 9:02 PMCitigroup Inc. Increases Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)marketbeat.com - March 16 at 5:43 AMAnalysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Pliant Therapeutics (PLRX)markets.businessinsider.com - March 12 at 8:10 PMMarketBeat Week in Review – 3/4 – 3/8 (BEAM)marketbeat.com - March 9 at 7:00 AMBeam Therapeutics Bolts Higher on Gene Therapy Licensing Paymentsmarketbeat.com - March 6 at 6:19 AM Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now BEAM Media Mentions By Week BEAM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BEAM News Sentiment▼0.380.44▲Average Medical News Sentiment BEAM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BEAM Articles This Week▼106▲BEAM Articles Average Week Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NTLA News KYMR News DNA News VCEL News SANA News FUSN News DNLI News RXRX News AMAM News CGON News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BEAM) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport Society1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
